Project Details
Short title | De-iron: A phase 2 study of the efficacy and safety of Deferasirox administered at early iron loading in patients with transfusion-dependent Myelodysplastic Syndromes |
---|---|
Status | Finished |
Effective start/end date | 1/06/12 → 31/07/20 |
Funding
- BLOODWISE
- NOVARTIS PHARMACEUTICALS UK LTD